| Literature DB >> 29439979 |
Farhana Mosaddeque1,2, Shusaku Mizukami3, Mohamed Gomaa Kamel4,5, Awet Alem Teklemichael1,2, Truong Van Dat6, Satoshi Mizuta7, Dinh Van Toan6, Ali Mahmoud Ahmed4,8, Nguyen Lam Vuong4,6, Mohamed Tamer Elhady4,9, Hoang Thi Nam Giang4,10, Tran Ngoc Dang4,6,11, Michiko Fukuda1, Lam K Huynh12, Yoshimasa Tanaka7, Timothy J Egan13, Osamu Kaneko2,14,15, Nguyen Tien Huy16,3, Kenji Hirayama17,2,15.
Abstract
The rapid spread of strains of malaria parasites that are resistant to several drugs has threatened global malaria control. Hence, the aim of this study was to predict the antimalarial activity of chemical compounds that possess anti-hemozoin-formation activity as a new means of antimalarial drug discovery. After the initial in vitro anti-hemozoin-formation high-throughput screening (HTS) of 9,600 compounds, a total of 224 hit compounds were identified as hemozoin inhibitors. These 224 compounds were tested for in vitro erythrocytic antimalarial activity at 10 μM by using chloroquine-mefloquine-sensitive Plasmodium falciparum strain 3D7A. Two independent experiments were conducted. The physicochemical properties of the active compounds were extracted from the ChemSpider and SciFinder databases. We analyzed the extracted data by using Bayesian model averaging (BMA). Our findings revealed that lower numbers of S atoms; lower distribution coefficient (log D) values at pH 3, 4, and 5; and higher predicted distribution coefficient (ACD log D) values at pH 7.4 had significant associations with antimalarial activity among compounds that possess anti-hemozoin-formation activity. The BMA model revealed an accuracy of 91.23%. We report new prediction models containing physicochemical properties that shed light on effective chemical groups for synthetic antimalarial compounds and help with in silico screening for novel antimalarial drugs.Entities:
Keywords: antimalarial; drug; hemozoin; malaria; prediction
Mesh:
Substances:
Year: 2018 PMID: 29439979 PMCID: PMC5923155 DOI: 10.1128/AAC.02424-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191